Organogenesis Holdings, Inc.

Industries Pharmaceuticals Biotechnology and Life Sciences
Subsidiaries Organogenesis Inc., Prime Merger Sub, LLC
Location Massachusetts
Activism

The biggest 3000 companies in the U.S. in the year of 2025.

Rating Overview

Risk Rating: Lower

Organogenesis Holdings, Inc. is Lower Risk.

Organogenesis Holdings, Inc. is Lower Risk. The company does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Overall, the company does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.

Rating Criteria

Corporate Weaponization Risk Levels
Criteria Risk Level
Cancellations Lower Risk
Discriminatory Philanthropy Lower Risk
Employment Protection High Risk

Corporate Weaponization

Corporate Governance and Public Policy Risk Levels
Criteria Risk Level
Advocacy Bias Medium Risk
Funding Lower Risk
Political Actions Lower Risk

Corporate Governance and Public Policy

Rating Criteria Detail

Criteria Risk Level Rationale

Corporate Weaponization


Criteria:

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level:

Lower

Rationale:

Organogenesis has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).

Criteria:

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level:

Lower

Rationale:

Organogenesis does not appear to discriminate against charitable organizations based on views or beliefs (1).

Criteria:

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level:

High

Rationale:

Organogenesis appears to prioritize diversity over merit in its leadership composition. From its Corporate Governance Guidelines: “In evaluating director candidates, the Board considers diversity of persons in terms of their expertise, age, gender, race, ethnicity, education, sexual orientation and other attributes” (1). The company does not provide viewpoint protections for its employees (2).

Corporate Governance and Public Policy


Criteria:

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Medium

Rationale:

Organogenesis supports DEI within its business practices. From its 2024 Annual Report: “We believe that diversity and inclusion in the workplace enhance employee engagement and stimulate innovation, and that people in diverse groups work better, share information more broadly and consider a wider range of views” (1). Otherwise, it has not supported ideological causes or policies (2).

Criteria:

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level:

Lower

Rationale:

Organogenesis has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria:

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level:

Lower

Rationale:

Organogenesis has not used its PAC donations or lobbying for ideological purposes (1)(2)(3).